However, mass-spectrometry-based interactome measurements cannot be readily scaled to survey the entire spectrum of clinical CF variants or how they are remodeled by the growing array of clinical and emerging pre-clinical CFTR modulators. Here, CFTR is linked to cystic fibrosis.